다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, v.17 no.10, 2013년, pp.e792 - e798
Momattin, H. , Mohammed, K. , Zumla, A. , Memish, Z.A. , Al-Tawfiq, J.A.
AI-Helper
The Middle East Respiratory Syndrome coronavirus (MERS-CoV) has been detected in a number of countries in the Middle East and Europe with an apparently high mortality rate. It is phylogenetically related to the SARS coronavirus and has also been associated with severe respiratory illness as well as ...
1 AlBarrak A.M. Stephens G.M. Hewson R. Memish Z.A. Recovery from severe novel coronavirus infection Saudi Med J 33 2012 1265 1269 23232672
2 CDC. Middle East Respiratory Syndrome. Available at: http://www.cdc.gov/coronavirus/mers/faq.html last accessed July 27, 2013.
3 Assiri A. McGeer A. Perl T.M. Hospital outbreak of Middle East respiratory syndrome coronavirus N Engl J Med 369 5 2013 407 416 23782161
4 Assiri A. Al-Tawfi q J.A. Al-Rabeeah A.A. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study Lancet Infect Dis 2013 published online July 26. http://dx.doi.org/10.1016/S1473-3099(13)70204-4
5 Stockman L.J. Bellamy R. Garner P. SARS: systematic review of treatment effects PLoS Med. 3 2006 e343 16968120
6 World Health Organization. Clinical management of severe acute respiratory infections when novel coronavirus is suspected: What to do and what not to do. Available at: http://www.who.int/csr/disease/coronavirus_infections/InterimGuidance_ClinicalManagement_NovelCoronavirus_11Feb13u.pdf
7 U.S. Preventive Services Task Force (August 1989). Guide to clinical preventive services: report of the U.S. Preventive Services Task Force. DIANE Publishing. pp. 24？. ISBN 978-1-56806-297-6.
8 Poutanen S.M. Low D.E. Henry B. Finkelstein S. Rose D. Green K. Identification of severe acute respiratory Syndrome in Canada N Eng J Med. 348 2003 1995 2005
9 Tsang K.W. Ho P.L. Ooi G.C. Yee W.K. Wang T. Chan-Yeung M. A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong N Eng J Med. 348 2003 1977 1985
10 Booth C.M. Matukas L.M. Tomlinson G.A. Rachlis A.R. Rose D.B. Dwosh H.A. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area JAMA. 290 2003 334 12865373
11 Hsu L.Y. Lee C.C. Green J.A. Ang B. Paton N.I. Lee L. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts Emerg Infect Dis. 9 2003 713 717 12781012
12 Peiris J.S. Chu C.M. Cheng V.C. Chan K.S. Hung I.F. Poon L.L. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study Lancet. 361 2003 1767 1772 12781535
13 Zhao Z. Zhang F. Xu M. Huang K. Zhong W. Cai W. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China J Med Microbiol. 52 2003 715 720 12867568
14 Sung J.J. Wu A. Joynt G.M. Yuen K.Y. Lee N. Chan P.K. Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak Thorax 59 2004 414 420 15115870
15 Ooi C.G. Khong P.L. Ho J.C. Lam B. Wong W.M. Yiu W.C. Severe Acute Respiratory Syndrome: Radiographic Evaluation and Clinical Outcome Measures Radiology 229 2003 500 506 14595150
16 Leong H.N. Ang B. Earnest A. Teoh C. Xu W. Leo Y.S. Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003 Trop Med Int Health. 9 2004 923 927 15303999
17 Chan K.S. Lai S.T. Chu C.M. Tsui E. Tam C.Y. Wong M.M. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study Hong Kong Med J 9 2003 399 406 14660806
18 Chu C.M. Cheng V.C. Hung I.F. Wong M.M. Chan K.H. Chan K.S. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings Thorax 59 2004 252 256 14985565
19 Yeh K.M. Chiueh T.S. Siu L.K. Lin J.C. Chan P.K. Peng M.Y. Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital J Antimicrob Chemother. 56 2005 919 922 16183666
20 Burnouf T. Radosevich M. Treatment of severe acute respiratory syndrome with convalescent plasma Hong Kong Med J. 9 2003 309 author reply 310 12904626
21 Cheng Y. Wong R. Soo Y.O. Wong W.S. Lee C.K. Ng M.H. Use of convalescent plasma therapy in SARS patients in Hong Kong Eur J Clin Microbiol Infect Dis. 24 2005 44 46 15616839
22 Soo Y.O. Cheng Y. Wong R. Hui D.S. Lee C.K. Tsang K.K. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS Patients Clin Microbiol Infect 10 2004 676 678 15214887
23 Loutfy M.R. Blatt L.M. Siminovitch K.A. Ward S. Wolff B. Lho H. Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study JAMA. 290 2003 3222 3228 14693875
24 Chan K.H. Chan J.F. Tse H. Chen H. Lau C.C. Cai J.P. Cross-reactive antibodies in convalescent SARS patients’ sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests J Infect. 67 2013 130 140 23583636
25 ISARIC, International Severe Acute Respiratory & Emerging Infection Consortium. Clinical Decision Making Tool for Treatment of MERS-CoV v.1.0, 18 June, 2013. Available at: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317139281416 last accessed July 26, 2013
26 Raj V.S. Mou H. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC Nature. 495 2013 251 254 23486063
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.